Suppression of lung cancer metastasis-related protein 1 promotes apoptosis in lung cancer cells

被引:11
作者
Xu, Yang [1 ]
Li, Chunsun [1 ]
Tian, Qing [1 ]
Li, Yanqin [1 ]
Yang, Zhen [1 ]
Liang, Zhixin [1 ]
Chen, Liangan [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing 100853, Peoples R China
基金
中国国家自然科学基金;
关键词
lung cancer metastasis-related protein 1; RNA interference; lung cancer; apoptosis; P53; PROLIFERATION; BAX; TUMORIGENESIS; PROGRESSION; FAMILY; DEATH; CYCLE;
D O I
10.3892/ijmm.2012.1160
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lung cancer is one of the most common human cancers and the leading cause of cancer-related death worldwide. The identification of lung cancer associated genes is essential for the diagnosis and treatment of this disease. Lung cancer metastasis-related protein 1 (LCMR1) is a novel gene cloned by differential display polymerase chain reaction in our laboratory. This study was designed to investigate the role of LCMR1 in the generation of apoptosis in lung cancer cells. RNA interference (RNAi) approach was used to knock down LCMR1 in lung cancer cells. The impacts of LCMR1 knockdown on the apoptosis of lung cancer cells were assessed using flow cytometry, quantitative real-time RT-PCR and western blotting. The results demonstrated that the inhibition of LCMR1 by RNAi enhanced apoptotic activity in lung cancer cells and this process required the involvement of p53. In addition, LCMR1 knockdown resulted in the upregulation of Bax and downregulation of Mcl-1. In conclusion, LCMR1 suppresses apoptosis in lung cancer cells and this effect is associated with multiple apoptosis-related proteins, including p53, Has and Mcl-1. These results provide new insights into the potential role of LCMR1 in the regulation of lung cancer carcinogenesis.
引用
收藏
页码:1481 / 1486
页数:6
相关论文
共 22 条
[1]  
Amaral JD, 2010, DISCOV MED, V9, P145
[2]   Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria [J].
Antonsson, B ;
Montessuit, S ;
Lauper, S ;
Eskes, R ;
Martinou, JC .
BIOCHEMICAL JOURNAL, 2000, 345 :271-278
[3]   The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death [J].
Basu, A ;
Haldar, S .
MOLECULAR HUMAN REPRODUCTION, 1998, 4 (12) :1099-1109
[4]   Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC [J].
Chen, Liangan ;
Liang, Zhixin ;
Tian, Qing ;
Li, Chunsun ;
Ma, Xiuqing ;
Zhang, Yu ;
Yang, Zhen ;
Wang, Ping ;
Li, Yanqin .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
[5]   Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis [J].
Chipuk, JE ;
Kuwana, T ;
Bouchier-Hayes, L ;
Droin, NM ;
Newmeyer, D ;
Schuler, M ;
Green, DR .
SCIENCE, 2004, 303 (5660) :1010-1014
[6]   Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study [J].
Cong, WM ;
Bakker, A ;
Swalsky, PA ;
Raja, S ;
Woods, J ;
Thomas, S ;
Demetris, AJ ;
Finkelstein, SD .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (03) :187-192
[7]   THE BCL-2 GENE FAMILY [J].
CRAIG, RW .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (01) :35-43
[8]   BCL-2 family proteins: Critical checkpoints of apoptotic cell death [J].
Danial, Nika N. .
CLINICAL CANCER RESEARCH, 2007, 13 (24) :7254-7263
[9]   Proliferation, cell cycle and apoptosis in cancer [J].
Evan, GI ;
Vousden, KH .
NATURE, 2001, 411 (6835) :342-348
[10]   Control of apoptosis by p53 [J].
Fridman, JS ;
Lowe, SW .
ONCOGENE, 2003, 22 (56) :9030-9040